Feng Meng

728 total citations
16 papers, 531 citations indexed

About

Feng Meng is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Feng Meng has authored 16 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Genetics. Recurrent topics in Feng Meng's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Eosinophilic Disorders and Syndromes (2 papers). Feng Meng is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Eosinophilic Disorders and Syndromes (2 papers). Feng Meng collaborates with scholars based in United States, China and Malaysia. Feng Meng's co-authors include Ji Yuan Wu, Nicholas J. Donato, Moshe Talpaz, Zhenghong Peng, William G. Bornmann, Mourad Majidi, Jack A. Roth, Henry Y. Lu, Bryant G. Darnay and Betty Lamothe and has published in prestigious journals such as Blood, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Feng Meng

16 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Meng United States 10 182 182 155 146 98 16 531
Gökben Baskaynak Germany 9 169 0.9× 207 1.1× 145 0.9× 148 1.0× 95 1.0× 14 464
Kristina Stefansson Sweden 8 181 1.0× 107 0.6× 84 0.5× 218 1.5× 43 0.4× 11 610
Mary C. Riedy United States 6 189 1.0× 90 0.5× 373 2.4× 111 0.8× 83 0.8× 10 841
Boris Brill Germany 15 266 1.5× 108 0.6× 183 1.2× 62 0.4× 20 0.2× 33 578
Karen R. McLachlan United States 10 377 2.1× 66 0.4× 130 0.8× 36 0.2× 53 0.5× 22 660
Reshmi Parameswaran United States 13 219 1.2× 57 0.3× 178 1.1× 40 0.3× 30 0.3× 27 525
Renate Schwab Australia 9 193 1.1× 77 0.4× 79 0.5× 62 0.4× 21 0.2× 16 358
Michael Plotnick United States 14 234 1.3× 114 0.6× 58 0.4× 53 0.4× 39 0.4× 15 715
Kateřina Machová Poláková Czechia 17 237 1.3× 549 3.0× 110 0.7× 359 2.5× 146 1.5× 50 818
S F Tsai United States 8 700 3.8× 122 0.7× 78 0.5× 91 0.6× 36 0.4× 9 942

Countries citing papers authored by Feng Meng

Since Specialization
Citations

This map shows the geographic impact of Feng Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Meng more than expected).

Fields of papers citing papers by Feng Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Meng. The network helps show where Feng Meng may publish in the future.

Co-authorship network of co-authors of Feng Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Meng. A scholar is included among the top collaborators of Feng Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Meng. Feng Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Jun, et al.. (2024). Loss in the rare bacterial diversity drives the monocropping obstacle of cut chrysanthemum. Journal of soil science and plant nutrition. 24(2). 2774–2785. 1 indexed citations
2.
3.
Meraz, Ismail M., Mourad Majidi, Ruping Shao, et al.. (2022). TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model. Communications Biology. 5(1). 167–167. 16 indexed citations
4.
Meraz, Ismail M., Mourad Majidi, Feng Meng, et al.. (2019). An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses. Cancer Immunology Research. 7(8). 1267–1279. 108 indexed citations
5.
6.
Gentile, Emanuela, Taro Oba, Jing Lin, et al.. (2017). Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics. Oncotarget. 8(29). 48222–48239. 6 indexed citations
7.
8.
Angelo, Laura S., Ji Yuan Wu, Feng Meng, et al.. (2011). Combining Curcumin (Diferuloylmethane) and Heat Shock Protein Inhibition for Neurofibromatosis 2 Treatment: Analysis of Response and Resistance Pathways. Molecular Cancer Therapeutics. 10(11). 2094–2103. 30 indexed citations
9.
Wu, Ji Yuan, Feng Meng, Ling-Yuan Kong, et al.. (2008). Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase. JNCI Journal of the National Cancer Institute. 100(13). 926–939. 121 indexed citations
10.
Donato, Nicholas J., Hanshi Sun, Feng Meng, et al.. (2008). Dasatinib Resistance in Patients with Chronic Myelogenous Leukemia: Identification of a Novel bcr-abl Kinase Domain Mutation. 2(4). 267–271. 2 indexed citations
11.
Wu, Ji Yuan, Feng Meng, Henry Y. Lu, et al.. (2008). Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells. Blood. 111(7). 3821–3829. 84 indexed citations
12.
13.
Donato, Nicholas J., Ji Yuan Wu, Ling Yuan Kong, et al.. (2004). Targeting BCR-ABL and Its Downstream Signaling Cascade as Therapy for Chronic Myelogenous Leukemia.. Blood. 104(11). 2964–2964. 1 indexed citations
14.
Nakamori, Mikihito, Xinping Fu, Feng Meng, et al.. (2003). Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms.. PubMed. 9(7). 2727–33. 53 indexed citations
15.
Wu, Wen-Shu, et al.. (2002). Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene. 21(24). 3925–3933. 27 indexed citations
16.
Pendurthi, Usha R., Feng Meng, Nigel Mackman, & L. Vijaya Mohan Rao. (2002). Mechanism of Resveratrol-mediated Suppression of Tissue Factor Gene Expression. Thrombosis and Haemostasis. 87(1). 155–162. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gökben Baskaynak Breakdown of academic impact, for papers by Kristina Stefansson Breakdown of academic impact, for papers by Mary C. Riedy Breakdown of academic impact, for papers by Boris Brill Breakdown of academic impact, for papers by Karen R. McLachlan Breakdown of academic impact, for papers by Reshmi Parameswaran Breakdown of academic impact, for papers by Renate Schwab Breakdown of academic impact, for papers by Michael Plotnick Breakdown of academic impact, for papers by Kateřina Machová Poláková Breakdown of academic impact, for papers by S F Tsai
Rankless by CCL
2026